Jim discusses his background, leadership style and his vision for Oraya's future with us.

Patients need to know what their ophthalmologist actually ‘does’, and what to expect when they are referred.

Market research requires that you examine three things: customers, the competition and the environment.

The last decade has seen some great advances, but there's still room for improvement…

Predicting treatment outcomes manages their expectations and improves your care.

Therapies based on stem cell treatments are considered to have tremendous potential in medicine.

If you had VMT or MH and could avoid vitrectomy, you would. Might ocriplasmin let you?

Five questions that must be answered on the causes and consequences of near-sightedness.

Bayer and Regeneron have presented the phase III trial data for aflibercept treatment of myopic choroidal neovascularization

Yet more ophthalmology acquisitions and licensing deals were announced this month